PDF icon Download PDF
Am J Perinatol 2025; 42(10): 1235-1242
DOI: 10.1055/a-2483-5910
SMFM Fellowship Series Article

Adverse Outcomes Associated with Progressive Intrahepatic Cholestasis of Pregnancy

Minhazur R. Sarker 
1   Department of Obstetrics, Gynecology and Reproductive Science, University of California San Diego, San Diego, California
2   Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York
3   Department of Obstetrics, Gynecology and Reproductive Science, New York City Health and Hospitals, Elmhurst Hospital Center, Elmhurst, New York
,
Dana Canfield
1   Department of Obstetrics, Gynecology and Reproductive Science, University of California San Diego, San Diego, California
,
Lauren Ferrara
2   Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York
3   Department of Obstetrics, Gynecology and Reproductive Science, New York City Health and Hospitals, Elmhurst Hospital Center, Elmhurst, New York
,
Gladys A. Ramos
1   Department of Obstetrics, Gynecology and Reproductive Science, University of California San Diego, San Diego, California
,
Chelsea A. DeBolt 
2   Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York
3   Department of Obstetrics, Gynecology and Reproductive Science, New York City Health and Hospitals, Elmhurst Hospital Center, Elmhurst, New York
› Author Affiliations
Funding M.R.S. is supported by NIH T32 HD007203-42 grant. Otherwise, no funding sources were utilized for this study.
› Further Information
Also available ateRefHebammen
   Permissions and Reprints
Preview

Abstract

Objective

This study aimed to assess the association between increasing bile acid levels in pregnancies with cholestasis and adverse outcomes.

Study Design

This is a retrospective cohort study of singleton, non-anomalous gestations complicated by cholestasis delivered at a single academic medical center from 2005 to 2019. We compared rates of adverse outcomes in pregnancies complicated by mild cholestasis (initial total bile acid [TBA] <40 μmol/L and peak TBA <40 μmol/L), progressive cholestasis (initial TBA <40 μmol/L and peak TBA ≥40 μmol/L), and severe cholestasis (initial TBA ≥40 μmol/L). Our primary outcome was a composite adverse outcome including spontaneous preterm labor and delivery, umbilical artery pH <7.20, 5-minute Apgar <7, cesarean delivery for nonreassuring fetal heart rate tracing, meconium-stained amniotic fluid, and neonatal intensive care unit (NICU) admission. Analyses were performed using mild cholestasis as the base comparator and a second analysis using severe cholestasis as the base comparator.

Results

Of the 1,182 pregnancies complicated by cholestasis, 732 (61.9%) had mild cholestasis, 78 (6.6%) had progressive cholestasis, and 372 (31.5%) had severe cholestasis. After adjusting for confounders including gestational age at diagnosis and using mild cholestasis as the base comparator, both progressive and severe cholestasis were associated with the composite adverse outcome (progressive intrahepatic cholestasis of pregnancy [ICP], OR = 1.70; 95% CI: 1.04–2.78 and severe ICP, OR = 1.60; 95% CI: 1.24–2.06). When using progressive cholestasis as the base comparator, there were no statistically significant differences in the primary or secondary outcomes between progressive cholestasis and severe cholestasis.

Conclusion

This study highlights the significance of monitoring peak bile acid levels and that some cases of cholestasis may progress in pregnancy and the adverse associations are better reflected by the peak TBA level and not the cholestasis severity at initial diagnosis.

Key Points

  • Outcomes with worsening cholestasis severity (progressive) are unknown.

  • Retrospective study comparing mild to progressive to severe cholestasis.

  • Progressive cholestasis outcomes are more similar to severe cholestasis.

  • Clinical utility of trending bile acids warrants further study.

Keywords

bile acids - cholestasis severity - hepatobiliary disease - intrahepatic cholestasis - preterm birth


Publication History

Received: 23 September 2024

Accepted: 22 November 2024

Accepted Manuscript online:
26 November 2024

Article published online:
24 December 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA